Cox John Insider Trading
Get the latest insider transactions of Cox John. Cox John is Director in REPLIGEN CORP ($RGEN) and EVP Pharmaceutical Oper & Tech in BIOGEN INC. ($IDPH) and Chief Executive Officer in Bioverativ Inc. ($BIVV) and in Sigilon Therapeutics, Inc. ($SGTX) and Director in Sigilon Therapeutics, Inc. ($SGTX). Discover the current value of Cox John shares.
Address: C/O BIOGEN IDEC INC. 133 BOSTON POST ROAD WESTON 02493MA
Cox John is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| IDPH | BIOGEN INC. | EVP Pharmaceutical Oper & Tech | 39,045 | 0.00 |
| RGEN | REPLIGEN CORP | Director | 923 | 26,988.52 |
| BIVV | Bioverativ Inc. | Chief Executive Officer | 0 | 0.00 |
| SGTX | Sigilon Therapeutics, Inc. | 4,444 |
Insider Trading Transactions of Cox John
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | SGTX | Sigilon Therapeutics, Inc ... | Cox John | Option Exercise | 9.97 | 8,888 | 88,613 | 8,888 | |
| Dec 10 2020 | SGTX | Sigilon Therapeutics, Inc ... | Cox John | Director | Buy | 0.00 | 4,444 | 0 | 4,444 |
| Dec 10 2020 | SGTX | Sigilon Therapeutics, Inc ... | Cox John | Director | Option Exercise | 0.00 | 4,444 | 0 | 0 |
| Mar 26 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | 96.72 | 1,858 | 179,706 | 923 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 12.91 | 14,000 | 180,740 | 16,781 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 41.19 | 3,632 | 149,602 | 20,413 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 26.12 | 3,366 | 87,920 | 23,779 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 38.76 | 2,434 | 94,342 | 26,213 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 42.07 | 3,304 | 138,999 | 29,517 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | 95.13 | 24,533 | 2,333,824 | 4,984 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | 96.45 | 1,187 | 114,486 | 3,797 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | 97.17 | 1,016 | 98,725 | 2,781 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 12.91 | 14,000 | 180,740 | 0 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 41.19 | 3,632 | 149,602 | 0 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 26.12 | 3,366 | 87,920 | 0 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 38.76 | 2,434 | 94,342 | 0 |
| Mar 20 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 42.07 | 3,304 | 138,999 | 0 |
| Mar 05 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 12.91 | 10,000 | 129,100 | 12,781 |
| Mar 05 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | 93.39 | 10,000 | 933,900 | 2,781 |
| Mar 05 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 12.91 | 10,000 | 129,100 | 14,000 |
| Feb 26 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | 94.85 | 100 | 9,485 | 7,136 |
| Feb 26 2020 | RGEN | REPLIGEN CORP | Cox John | Director | Sell | 92.76 | 4,355 | 403,970 | 2,781 |
| May 17 2019 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 0.00 | 923 | 0 | 7,236 |
| May 17 2019 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 67.71 | 2,109 | 142,800 | 2,109 |
| May 17 2018 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 0.00 | 1,486 | 0 | 6,313 |
| May 17 2018 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 42.07 | 3,304 | 138,999 | 3,304 |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 0.00 | 185,094 | 0 | 0 |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 0.00 | 136,364 | 0 | 0 |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 0.00 | 48,678 | 0 | 0 |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 7.82 | 48,230 | 377,159 | 0 |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 44.51 | 387,366 | 17,241,661 | 0 |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 44.51 | 193,683 | 8,620,830 | 0 |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 104.30 | 13,973 | 1,457,384 | 190,888 |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 104.74 | 5,794 | 606,864 | 185,094 |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Buy | 0.00 | 24,339 | 0 | 215,680 |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 103.52 | 10,819 | 1,119,983 | 204,861 |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 0.00 | 24,339 | 0 | 48,678 |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Buy | 9.53 | 18,381 | 175,171 | 199,013 |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 103.05 | 7,672 | 790,600 | 191,341 |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 9.53 | 18,381 | 175,171 | 0 |
| May 22 2017 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 0.00 | 1,206 | 0 | 4,827 |
| May 22 2017 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 38.76 | 2,434 | 94,342 | 2,434 |
| Apr 03 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 54.46 | 8,416 | 458,335 | 180,632 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Buy | 0.00 | 211,679 | 0 | 226,979 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 43.42 | 3,404 | 147,802 | 223,575 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 49.56 | 3,383 | 167,661 | 220,192 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 47.76 | 8,355 | 399,035 | 211,837 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 43.42 | 6,986 | 303,332 | 204,851 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 49.56 | 2,641 | 130,888 | 202,210 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 47.76 | 6,436 | 307,383 | 195,774 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Sell | 43.42 | 6,726 | 292,043 | 189,048 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 7.82 | 48,230 | 377,159 | 48,230 |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 9.53 | 18,381 | 175,171 | 18,381 |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 0.00 | 73,017 | 0 | 73,017 |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 44.51 | 193,337 | 8,605,430 | 193,337 |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 44.51 | 386,675 | 17,210,904 | 386,675 |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 0.00 | 73,017 | 0 | 73,017 |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 44.51 | 193,337 | 8,605,430 | 193,337 |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Offic ... | Option Exercise | 44.51 | 386,675 | 17,210,904 | 386,675 |
| May 13 2016 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 0.00 | 1,763 | 0 | 3,621 |
| May 13 2016 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 26.12 | 3,366 | 87,920 | 3,366 |
| Apr 05 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Buy | 0.00 | 8,444 | 0 | 39,045 |
| Feb 25 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Buy | 0.00 | 810 | 0 | 30,898 |
| Feb 25 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Sell | 258.99 | 382 | 98,934 | 30,516 |
| Feb 25 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 0.00 | 810 | 0 | 6,450 |
| Feb 25 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 0.00 | 1,608 | 0 | 4,842 |
| Feb 24 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 0.00 | 11,850 | 0 | 11,850 |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Buy | 0.00 | 1,052 | 0 | 29,394 |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Sell | 247.22 | 495 | 122,374 | 28,899 |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Buy | 0.00 | 2,246 | 0 | 31,145 |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Sell | 247.22 | 1,057 | 261,312 | 30,088 |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 0.00 | 1,052 | 0 | 3,842 |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 0.00 | 2,246 | 0 | 2,249 |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 0.00 | 1,394 | 0 | 2,448 |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Buy | 0.00 | 4,026 | 0 | 29,666 |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Sell | 250.77 | 1,324 | 332,019 | 28,342 |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 0.00 | 4,026 | 0 | 0 |
| May 26 2015 | RGEN | REPLIGEN CORP | Cox John | Director | Buy | 0.00 | 1,858 | 0 | 1,858 |
| May 26 2015 | RGEN | REPLIGEN CORP | Cox John | Director | Option Exercise | 41.19 | 3,632 | 149,602 | 3,632 |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Buy | 72.87 | 2,175 | 158,492 | 34,686 |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Buy | 60.56 | 2,891 | 175,079 | 37,577 |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Sell | 449.06 | 12,010 | 5,393,211 | 25,567 |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 72.87 | 2,175 | 158,492 | 0 |
| Mar 26 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 60.56 | 2,891 | 175,079 | 2,892 |
| Feb 25 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical Op ... | Option Exercise | 0.00 | 7,260 | 0 | 7,260 |